Shu-Chih Su, Ph.D.

2008 Johns Hopkins University, Baltimore, MD 
Biostatistics Biology, Neuroscience Biology
"Shu-Chih Su"


Sign in to add mentor
Brian Caffo grad student 2008 Johns Hopkins
 (Structure/function relationships in the analysis of anatomical and functional neuroimaging data.)
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Mullane KM, Morrison VA, Camacho LH, et al. (2019) Safety and efficacy of inactivated varicella zoster virus vaccine in immunocompromised patients with malignancies: a two-arm, randomised, double-blind, phase 3 trial. The Lancet. Infectious Diseases
Winston DJ, Mullane KM, Cornely OA, et al. (2018) Inactivated varicella zoster vaccine in autologous haemopoietic stem-cell transplant recipients: an international, multicentre, randomised, double-blind, placebo-controlled trial. Lancet (London, England). 391: 2116-2127
Levin MJ, Schmader KE, Pang L, et al. (2015) Cellular and Humoral Responses to a Second Dose of Herpes Zoster Vaccine Administered 10 Years After the First Dose Among Older Adults. The Journal of Infectious Diseases
Gilbert PB, Gabriel EE, Hudgens MG, et al. (2015) Reply to Dunning. The Journal of Infectious Diseases. 212: 1521-3
Russell AF, Parrino J, Fisher CL, et al. (2015) Safety, tolerability, and immunogenicity of zoster vaccine in subjects on chronic/maintenance corticosteroids. Vaccine. 33: 3129-34
Morrison VA, Johnson GR, Schmader KE, et al. (2015) Long-term persistence of zoster vaccine efficacy. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 60: 900-9
Gilbert PB, Gabriel EE, Miao X, et al. (2014) Fold rise in antibody titers by measured by glycoprotein-based enzyme-linked immunosorbent assay is an excellent correlate of protection for a herpes zoster vaccine, demonstrated via the vaccine efficacy curve. The Journal of Infectious Diseases. 210: 1573-81
Levin MJ, Schmader KE, Gnann JW, et al. (2013) Varicella-zoster virus-specific antibody responses in 50-59-year-old recipients of zoster vaccine. The Journal of Infectious Diseases. 208: 1386-90
Mehrotra DV, Su SC, Li X. (2012) An efficient alternative to the stratified Cox model analysis. Statistics in Medicine. 31: 1849-56
Schmader KE, Levin MJ, Gnann JW, et al. (2012) Efficacy, safety, and tolerability of herpes zoster vaccine in persons aged 50-59 years. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 54: 922-8
See more...